Effects of Alpha-Lipoic Acid Supplementation on Cardiovascular Disease Risk Factors in β-Thalassemia Major Patients: A Clinical Trial Crossover Study.
Khadijeh JamshidiHadi AbdollahzadMostafa NachvakMansour RezaeiMohammad Reza GolpayeganiElham Sharifi-ZahabiPublished in: Journal of blood medicine (2020)
The results of this study showed that after 8-wk of ALA consumption, the serum OPG reduced significantly in β-thalassemia major patients. Therefore, controlling the serum OPG level with ALA consumption can be an important complementary therapeutic option to prevent the progression of CVD in β-thalassemia major patients.